|
|
|
Volumn 10, Issue 6, 1996, Pages 383-384
|
|
FDA grants marketing clearance of VISTIDE® for the treatment of CMV retinitis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIDOFOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CYTOMEGALOVIRUS INFECTION;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NEPHROTOXICITY;
NOTE;
RETINITIS;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS RETINITIS;
CYTOSINE;
DRUG APPROVAL;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0030454660
PISSN: 08935068
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|